Fibroblast growth factor 21 in cardio-metabolic disorders: a systematic review and meta-analysis

FGF21 significantly predicts the incidence of coronary artery disease, the risks of metabolic syndrome, diabetes mellitus and renal progression in diabetes. It also predicted all-cause and cardiovascular mortality.